Piombino Dese, Italy–based Stevanato Group’s IPO resulted in net proceeds of approximately $453.5 […] Tenaya Therapeutics announced that it priced an underwritten, upsized initial public offering of ...
HC Wainwright reissued their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report ...
In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa ...
Tenaya Therapeutics (TNYA) announced that the California Institute for Regenerative Medicine, CIRM,, a state of California Agency that funds ...
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...
In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback